
Riccardo Barrile, PhD
Glioblastoma
Customized tumor modeling platform
Coronavirus COVID-19 Updates: uc.edu/publichealth
University of Cincinnati Brain Tumor Center members specialize in discovery and translational research in disciplines including epigenetics, metabolomics, pharmaceutical sciences, cancer etiology and more.
Visit the webpages of BTC Research Investigators to learn about our research programs.
Glioblastoma
Customized tumor modeling platform
Cancer signaling & metabolism
Brain development and glioblastoma
Pharmacokinetics & Pharmacodynamics
Drug Metabolism
Repurposed therapeutics & Glioblastoma
IDH1 mutant glioma
Glioblastoma
Transcriptional control Olig2
Pediatric brain tumors
Tumor-vascular interactions
Mouse models and preclinical testing
RNA-based therapeutics
GABAa receptor
Focused ultrasound drug delivery
Tumor metabolism
Signaling control
Experimental therapeutics
Glioblastoma
Brain metastases & Phospholipid targeting
Therapeutic discovery & Novel imaging modality
Metastatic tumors & Glioblastoma
Nucleotide metabolism & Repurposed therapeutics
Neuro-oncology & Clinical trials
GABAa receptor
Brain metastasis – melanoma & lung Glioblastoma Medulloblastoma
Glioblastoma
Drug delivery nanomaterials
Tuberous Sclerosis
Glioblastoma
Breast cancer brain metastasis & Autophagy & Bioenergy
The Brain Tumor Center is directed by Dr. Mario Zuccarello MD, Department of Neurosurgery. Dr. Soma Sengupta MD PhD is the BTC Associate Director for Clinical Trials, and Dr. David Plas is the BTC Associate Director for Research.
Membership is available to all investigators with an interest in primary or metastatic brain tumors in the clinical and research communities at University of Cincinnati, Cincinnati Children’s Hospital Medical Center, and the Cincinnati VA Medical Center.